KRT13 and urothelial carcinoma: These intermediate cells give rise to the luminal subtype of urothelial carcinoma and our results showed that expression of KRT13 mRNA in the RT4 cell line was low and treatment with As3+ further decreased the expression of this gene (Supplemental Figure S1A).